Brief: Reviva Pharmaceuticals Holdings, Inc. Announces $8.5 Million Registered Direct Offering And Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

Reviva Pharmaceuticals Holdings

06/09/2022 13:33

Sept 6 (Reuters) - Reviva Pharmaceuticals Holdings, Inc.
 RVPH.O :
    * REVIVA PHARMACEUTICALS HOLDINGS, INC. ANNOUNCES $8.5
MILLION
REGISTERED DIRECT OFFERING AND CONCURRENT PRIVATE PLACEMENT
PRICED AT-THE-MARKET UNDER NASDAQ RULES
    * REVIVA PHARMACEUTICALS HOLDINGS, INC. - SALE OF 3.4
MILLION
SHARES AT PRICE PER SHARE OF $2.53
    * REVIVA PHARMACEUTICALS HOLDINGS, INC. - INTENDS TO USE NET
PROCEEDS FROM OFFERING TO CONTINUE CLINICAL DEVELOPMENT OF
BRILAROXAZINE

Source text for Eikon:  ID:nGNX6WkDDP 
Further company coverage:  RVPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))